federal_register: 95-9701
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 95-9701 | Drug Products Containing Quinine for the Treatment and/or Prevention of Malaria for Over-The-Counter Human Use | Proposed Rule | The Food and Drug Administration (FDA) is issuing a notice of proposed rulemaking that would establish that over-the-counter (OTC) drug products containing quinine for the treatment and/or prevention of malaria are not generally recognized as safe and are misbranded. FDA is issuing this notice of proposed rulemaking after considering data and information on the safety of quinine. | 1995-04-19 | 1995 | 4 | https://www.federalregister.gov/documents/1995/04/19/95-9701/drug-products-containing-quinine-for-the-treatment-andor-prevention-of-malaria-for-over-the-counter | https://www.govinfo.gov/content/pkg/FR-1995-04-19/pdf/95-9701.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is issuing a notice of proposed rulemaking that would establish that over-the-counter (OTC) drug products containing quinine for the treatment and/or prevention of malaria are not generally recognized as safe and... |